Helicobacter pylori infection and peptic ulcer disease

作者: Peter Malfertheiner

DOI: 10.1007/978-3-0348-8795-3_11

关键词:

摘要: At the stage when peptic ulcers appeared to become clinically controlled by more and potent acid inhibitory agents, traditional concept of ulcer pathogenesis was turned upside down discovery a microorganism specialized infect human gastric mucosa. Helicobacter pylori infection is now recognized as predisposing key factor has assigned contributory though important role in duodenal ulcerogenesis. The this bacterium reopened chapters physiology pathophysiology substantially modified clinical management disease offering anti-H. therapy definitive cure for great majority patients suffering from ulcers. new classification attains clear distinction H. pylori-positive or other less frequent etiologies (Tab. 1), thereby addressing proper each entity. Management consists antibiotics addition acid-suppressive agents.

参考文章(115)
Douglas W. Burget, Stephen G. Chiverton, Richard H. Hunt, Is there an optimal degree of acid suppression for healing of duodenal ulcers? Gastroenterology. ,vol. 99, pp. 345- 351 ,(1990) , 10.1016/0016-5085(90)91015-X
Erik A.J. Rauws, Wies Langenberg, Guido N.J. Tytgat, Hendrik J. Houthoff, H.C. Zanen, Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. ,vol. 94, pp. 33- 40 ,(1988) , 10.5555/URI:PII:0016508588906063
G. I. Perez-Perez, J. C. Atherton, R. M. Peek, G. G. Miller, Xiaoming Zhao, K. T. Tham, M. J. Blaser, Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Laboratory Investigation. ,vol. 73, pp. 760- 770 ,(1995)
K. E. L. McColl, E. El-Omar, Effect of H. pylori infection on gastrin and gastric acid secretion Springer, Dordrecht. pp. 245- 256 ,(1994) , 10.1007/978-94-011-1418-9_21
Rühl Gh, Stolte M, Börsch G, Tillenburg B, Becker T, Sollböhmer M, Labenz J, One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology. ,vol. 7, pp. 9- 11 ,(1995)
J. Labenz, G. H. Rühl, G. Börsch, Ee. Gyenes, Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. The American Journal of Gastroenterology. ,vol. 88, pp. 491- 495 ,(1993)
Bruce E. Dunn, Pathogenic mechanisms of Helicobacter pylori Gastroenterology Clinics of North America. ,vol. 22, pp. 43- 57 ,(1993) , 10.1016/S0889-8553(21)00262-4
Norrby A, Jaup Bh, Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. The American Journal of Gastroenterology. ,vol. 90, pp. 943- 945 ,(1995)
M. J. Blaser, C. W. Stratton, B. Marshall, D. Y. Graham, J. Drnec, P. Prokocimer, R. M. Genta, W. L. Peterson, P. D. Klein, N. Siepman, Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. The American Journal of Gastroenterology. ,vol. 88, pp. 1860- 1864 ,(1993)
P. Moayyedi, D. S. Tompkins, P. Sahay, A. T. R. Axon, Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. European Journal of Gastroenterology & Hepatology. ,vol. 7, pp. 835- 840 ,(1995)